If ALKS get coverage on Cramer's show, it will be a real positive. The company has something like 5 drugs earning money and a solid pipeline. It is also sitting pretty in the mental health field as its long acting drugs could provide to be a real asset in keeping people with mental illness properly medicated. A once a month shot is easy to administer and monitor. Its medications to keep people from relapsing with alcohol and drugs is also in a sweet spot which should undergo considerable growth. If ALKS gets coverage by Cramer, I am sure the fact that the company is now based in Ireland and subject to much lower taxes will also get metioned. After hours or tomorrow morning could be rough on shorts.